Coronavirus

The findings showed that 63 of the 9119 patients with severe COVID-19 infection contracted the virus a second time, with an average reinfection period of 116 days.

A lower antibody response found in one-fourth of patients taking methotrexate does not necessarily mean that these patients are not protected against COVID-19.

New protocol for processing saliva samples with a bead mill homogenizer before real-time PCR testing has shown higher sensitivity to COVID-19 than nasopharyngeal swab testing

The investigators created a panel of pseudotype viruses, which combined the HIV virus and SARS-CoV-2 spike protein.

The Novavax COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall in a phase 3 trial.

Susan Lang, MA, MBA, the CEO of XIL Health, discusses how pharmacies that have already been hard hit by the pandemic may be impacted if Pfizer goes through with their projected increased in COVID-19 vaccine prices.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Although the United States has surpassed the milestone of 100 million COVID-19 vaccinations, a study found that reaching 200 million will be significantly more challenging as vaccine hesitancy remains.

Here are 3 questions regarding pharmacists' role in a massive health care undertaking.

Because study coordinators were unable to travel, research pharmacist Brian Wortz, PharmD, said researchers were forced to adapt quickly and figure out what they could do remotely.

Concerns surrounding the vaccination of this population stemmed from the effects that cancer and its treatments can have on the immune system, but the investigators said this study should alleviate those fears.

The collaborative effort by pharmacies, which include Walgreens, CVS, and Albertsons Company stores, is part of the National Month of Action for COVID-19 vaccinations.

Susan Lang, MA, MBA, CEO of XIL Health and former senior executive at Express Scripts, on some of the ways pharmacies have been affected by the COVID-19 pandemic over the past year.

Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, discusses the value of the pharmacist in administering COVID-19 vaccines to adolescents and children.

The study also found significant variation in treatment of children and adolescents hospitalized with COVID-19.

Several third-year pharmacy students at the Washington State University College of Pharmacy and Pharmaceutical Sciences said they were involved with COVID-19 testing and vaccination efforts, including organizing mass vaccination events and testing patients in their communities.

Common precautions to prevent the spread of COVID-19 also decreased the rates of common respiratory illnesses in 2020 and early 2021.

Patients receiving dialysis are required to receive their treatments in clinics multiple times a week, meaning they were unable to effectively self-isolate.

Post pandemic, these concepts are hitting the mainstream in the payer, policymaker environment.

The researchers found that the proportion of patients requiring in-patient endoscopic interventions for their alcohol-related gastrointestinal and liver conditions increased.

Catherine Duggan, FRPharmS, CEO of International Pharmaceutical Federation, discusses the role and the authorities of the pharmacist internationally, and the effect the pandemic has had on that role globally.

Findings showed a 34% decrease in the number of mental health services utilized by children under age 19 and a 22% decline in the number of mental health services utilized by adults aged 19 to 64.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Not only are pharmacists drug experts, but the pandemic demonstrated that they can also perform COVID-19 testing and vaccinations alongside physicians and other health care providers.

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses some of the reimbursement issues that have been arising for pharmacies while administering COVID-19 vaccines.

Lynlee Burton, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, discusses the significance of short vaccine development timelines on the future development of COVID-19 vaccines.

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses the impact of declining reimbursements on pharmacies that were already hard hit by the COVID-19 pandemic.

New research results show that over the next decade COVID-19 may be more like the common cold.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

No cases of COVID-19 were observed in the vaccine group using the case definition from the adult phase 3 COVE study, compared to 4 cases in the placebo group.